Financhill
Buy
91

ALMS Quote, Financials, Valuation and Earnings

Last price:
$19.55
Seasonality move :
25.19%
Day range:
$18.10 - $19.91
52-week range:
$2.76 - $22.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
63.98x
P/B ratio:
5.31x
Volume:
6M
Avg. volume:
4.1M
1-year change:
154.36%
Market cap:
$2B
Revenue:
--
EPS (TTM):
-$3.85

Analysts' Opinion

  • Consensus Rating
    Alumis, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $37.29, Alumis, Inc. has an estimated upside of 90.62% from its current price of $19.56.
  • Price Target Downside
    According to analysts, the lowest downside price target is $32.00 representing -63.6% downside risk from its current price of $19.56.

Fair Value

  • According to the consensus of 7 analysts, Alumis, Inc. has 90.62% upside to fair value with a price target of $37.29 per share.

ALMS vs. S&P 500

  • Over the past 5 trading days, Alumis, Inc. has overperformed the S&P 500 by 115.05% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Alumis, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Alumis, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Alumis, Inc. reported revenues of $2.1M.

Earnings Growth

  • Alumis, Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Alumis, Inc. reported earnings per share of -$1.06.
Enterprise value:
1.7B
EV / Invested capital:
--
Price / LTM sales:
63.98x
EV / EBIT:
--
EV / Revenue:
76.94x
PEG ratio (5yr expected):
-0.05x
EV / Free cash flow:
-4.56x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$18.7M
Return On Assets:
-57.99%
Net Income Margin (TTM):
-1108.24%
Return On Equity:
-74.43%
Return On Invested Capital:
-67.45%
Operating Margin:
-5585.29%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue -- -- $22.1M -- $2.1M
Gross Profit -$558K -$3.1M $18.7M -$814K $1.2M
Operating Income -- -$242.3M -$441.3M -$98.4M -$115.4M
EBITDA -- -$239.2M -$437.8M -$97.6M -$114.5M
Diluted EPS -$2.23 -$4.47 -$3.85 -$1.71 -$1.06
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets -- -- -- $377.3M $393.3M
Total Assets -- -- -- $412.6M $488M
Current Liabilities -- -- -- $33.5M $65.4M
Total Liabilities -- -- -- $64.2M $103.2M
Total Equity -- -- -- $348.4M $384.8M
Total Debt -- -- -- $29.6M $33.4M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -- -$214M -$372.4M -$83.8M -$110.9M
Cash From Investing -- -$148.9M $223.8M -$93.2M $24M
Cash From Financing -- $522.1M $754K $235.2M --
Free Cash Flow -- -$216.6M -$373.4M -$84.5M -$110.9M
ALMS
Sector
Market Cap
$2B
$28.1M
Price % of 52-Week High
87.71%
51.87%
Dividend Yield
0%
0%
Shareholder Yield
-0.48%
-1.59%
1-Year Price Total Return
154.36%
-17.31%
Beta (5-Year)
--
0.495
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $13.79
200-day SMA
Buy
Level $5.51
Bollinger Bands (100)
Buy
Level 3.16 - 9.98
Chaikin Money Flow
Sell
Level -50M
20-day SMA
Buy
Level $12.31
Relative Strength Index (RSI14)
Buy
Level 80.98
ADX Line
Buy
Level 46.85
Williams %R
Sell
Level -18.9619
50-day SMA
Buy
Level $8.71
MACD (12, 26)
Buy
Level 2.24
25-day Aroon Oscillator
Buy
Level 84
On Balance Volume
Neutral
Level 127.6M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-1.5439)
Sell
CA Score (Annual)
Level (-5.9004)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (8.0356)
--
Piotroski F Score (Annual)
Level (--)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (3)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.

Stock Forecast FAQ

In the current month, ALMS has received 7 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ALMS average analyst price target in the past 3 months is $37.29.

  • Where Will Alumis, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Alumis, Inc. share price will rise to $37.29 per share over the next 12 months.

  • What Do Analysts Say About Alumis, Inc.?

    Analysts are divided on their view about Alumis, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Alumis, Inc. is a Sell and believe this share price will drop from its current level to $32.00.

  • What Is Alumis, Inc.'s Price Target?

    The price target for Alumis, Inc. over the next 1-year time period is forecast to be $37.29 according to 7 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is ALMS A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Alumis, Inc. is a Buy. 7 of 7 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of ALMS?

    You can purchase shares of Alumis, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Alumis, Inc. shares.

  • What Is The Alumis, Inc. Share Price Today?

    Alumis, Inc. was last trading at $19.55 per share. This represents the most recent stock quote for Alumis, Inc.. Yesterday, Alumis, Inc. closed at $19.56 per share.

  • How To Buy Alumis, Inc. Stock Online?

    In order to purchase Alumis, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Shopify Stock a Good Buy Now?
Is Shopify Stock a Good Buy Now?

eCommerce technology platform Shopify (NASDAQ:SHOP) delivered impressive returns in 2025…

Will The Magnificent 7 Stocks Go Up This Year?
Will The Magnificent 7 Stocks Go Up This Year?

2025 was another banner year for the Magnificent Seven stocks,…

Why Did Planet Labs Stock Rally So Much?
Why Did Planet Labs Stock Rally So Much?

Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
100
ATGL alert for Jan 10

Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.

Buy
71
NAIL alert for Jan 10

Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.

Buy
54
LGIH alert for Jan 10

LGI Homes, Inc. [LGIH] is up 13.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock